Reckitt Benckiser Healthcare International Limited
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- GALIEVE I DOSPÅSE oral suspension 500 mg/10 ml+213 mg/10 ml+325 mg/10 ml
- GALIEVE MINT I DOSPÅSE oral suspension 500 mg/10 ml+213 mg/10 ml+325 mg/10 ml
- GALIEVE MINT oral suspension 50 mg/ml+21.3 mg/ml+32.5 mg/ml
- GALIEVE PEPPERMINT chewable tablet 250 mg+133.5 mg+80 mg
- M01 - Antiinflamatorios y antirreumáticos
- NUROFEN APELSIN oral suspension 40 mg/ml
- NUROFEN chewable tablet 100 mg
- NUROFEN JORDGUBB oral suspension 40 mg/ml
- R02 - Preparados para la garganta
- STREFEN APELSIN lozenge 8.75 mg
- STREFEN HONUNG & CITRON oromucosal spray 16.2 mg/ml
- STREFEN lozenge 8.75 mg
- STREFEN oromucosal spray 16.2 mg/ml
- STREPSILS APELSIN lozenge 1.2 mg+0.6 mg
- STREPSILS CITRON lozenge 1.2 mg+0.6 mg
- STREPSILS HONEY & LEMON lozenge 1.2 mg+0.6 mg
- STREPSILS INGEFÄRA lozenge 1.2 mg+0.6 mg
- STREPSILS JORDGUBB lozenge 1.2 mg+0.6 mg
- STREPSILS MINT lozenge 1.2 mg+0.6 mg